Acquired genetic mechanisms of a multiresistant bacterium isolated from a treatment plant receiving wastewater from antibiotic production

Applied and Environmental Microbiology

Volumn 79, Issue 23, 2013, Pages 7256-7263

  Johnning, Anna ^a   Moore, Edward R B ^a   Svensson Stadler, Liselott ^a   Shouche, Yogesh S ^b   Joakim Larsson, D G ^a   Kristiansson, Erik ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SUSCEPTIBILITIES; HORIZONTAL GENE TRANSFER; INDUSTRIAL WASTEWATERS; OCHROBACTRUM INTERMEDIUM; PHARMACEUTICAL PRODUCTION; WASTEWATER TREATMENT PLANTS;

AMIDES; AMINO ACIDS; BACTERIA; GENE TRANSFER; GENES; SULFUR COMPOUNDS;

ANTIBIOTICS;

ANTIBIOTIC RESISTANCE; BACTERIUM; GENE EXPRESSION; GENETIC ANALYSIS; GENOME; ORGANIC COMPOUND; WASTEWATER; WATER TREATMENT;

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; DNA SEQUENCE; DRUG EFFECT; GENETICS; HORIZONTAL GENE TRANSFER; INDIA; INDUSTRIAL WASTE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; OCHROBACTRUM; TRANSPOSON; WASTE WATER;

ANTI-BACTERIAL AGENTS; DNA MUTATIONAL ANALYSIS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; GENE TRANSFER, HORIZONTAL; GENOME, BACTERIAL; INDIA; INDUSTRIAL WASTE; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; OCHROBACTRUM; SEQUENCE ANALYSIS, DNA; WASTE WATER;

EID: 84888226285     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02141-13     Document Type: Article

References (64)

1. Cars O, Hedin A, Heddini A. 2011. The global need for effective antibiotics-moving towards concerted action. Drug Resist. Updates 14: 68-69.
2. Tenover FC. 2006. Mechanisms of antimicrobial resistance in bacteria. Am. J. Med. 119: S3-S10.
3. Kümmerer K. 2009. Antibiotics in the aquatic environment-a review, part II. Chemosphere 75: 435-441.
4. Kümmerer K. 2009. Antibiotics in the aquatic environment-a review, part I. Chemosphere 75: 417-434.
5. Zhang XX, Zhang T, Fang HHP. 2009. Antibiotic resistance genes in water environment. Appl. Microbiol. Biotechnol. 82: 397-414.
6. Canton R. 2009. Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting. Clin. Microbiol. Infect. 15(Suppl 1): 20-25.
7. Gaze W, Krone S, Larsson DGJ, Li X, Robinson J, Simonet P, Smalla K, Timinouni M, Topp E, Wellington E. 2013. Influence of humans on evolution and mobilization of environmental antibiotic resistome. Emerg. Infect. Dis. vol 19. doi: 10.3201/eid1907.120871.
8. Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI. 2011. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 7: e1002158. doi: 10.1371/journal.ppat.1002158.
9. Martinez JL. 2008. Antibiotics and antibiotic resistance genes in natural environments. Science 321: 365-367.
10. Baquero F, Martínez J-L, Cantón R. 2008. Antibiotics and antibiotic resistance in water environments. Curr. Opin. Biotechnol. 19: 260-265.
11. Pruden A, Larsson DGJ, Amézquita A, Collignon P, Brandt KK, Graham DW, Lazorchak JM, Suzuki S, Silley P, Snape JR. 2013. Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ. Health Perspect. 121: 878-885.
12. Fick J, Soderstrom H, Lindberg RH, Phan C, Tysklind M, Larsson DGJ. 2009. Contamination of surface, ground, and drinking water from pharmaceutical production. Environ. Toxicol. Chem. 28: 2522-2527.
13. Larsson DGJ, de Pedro C, Paxeus N. 2007. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazard. Mater. 148: 751-755.
14. Li D, Yang M, Hu J, Ren L, Zhang Y, Li K. 2008. Determination and fate of oxytetracycline and related compounds in oxytetracycline production wastewater and the receiving river. Environ. Toxicol. Chem. 27: 80-86.
15. Li D, Yang M, Hu J, Zhang Y, Chang H, Jin F. 2008. Determination of penicillin G and its degradation products in a penicillin production wastewater treatment plant and the receiving river. Water Res. 42: 307-317.
16. Babic S, Mutavdzic D, Asperger D, Horvat AJM, Kastelan-Macan M. 2007. Determination of veterinary pharmaceuticals in production wastewater by HPTLC-videodensitometry. Chromatographia 65: 105-110.
17. Sim W-J, Lee J-W, Lee E-S, Shin S-K, Hwang S-R, Oh J-E. 2011. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 82: 179-186.
18. Folkehelseinstituttet. 2008. Vurdering av riskiko ved utslipp av bacitracin med avløpsvann. Folkehelseinstituttet, Oslo, Norway.
19. Gunnarsson L, Kristiansson E, Rutgersson C, Sturve J, Fick J, Förlin L, Larsson DGJ. 2009. Pharmaceutical industry effluent diluted 1: 500 affects global gene expression, cytochrome P450 1A activity, and plasma phosphate in fish. Environ. Toxicol. Chem. 28: 2639-2647.
20. Carlsson G, Orn S, Larsson DGJ. 2009. Effluent from bulk drug production is toxic to aquatic vertebrates. Environ. Toxicol. Chem. 28: 2656-2662.
21. Rutgersson C, Gunnarsson L, Fick J, Kristiansson E, Larsson DGJ. 2013. Oral exposure to industrial effluent with exceptionally high levels of drugs does not indicate acute toxic effects in rats. Environ. Toxicol. Chem. 32: 577-584.
22. Beijer K, Gao K, Jönsson ME, Larsson DGJ, Brunström B, Brandt I. 2013. Effluent from drug manufacturing affects cytochrome P450 1 regulation and function in fish. Chemosphere 90: 1149-1157.
23. Kristiansson E, Fick J, Janzon A, Grabic R, Rutgersson C, Weijdegård B, Söderström H, Larsson DGJ. 2011. Pyrosequencing of antibioticcontaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS One 6: e17038. doi: 10.1371/journal.pone.0017038.
24. Marathe NP, Regina VR, Walujkar SA, Charan SS, Moore ERB, Larsson DGJ, Shouche YS. A treatment plant receiving waste water from multiple bulk drug manufacturers is a reservoir for highly multi-drug resistant integron-bearing bacteria. PLoS One, in press. doi: 10.1371/journal.pone.0077310.
25. Thoma B, Straube E, Scholz HC, Al Dahouk S, Zöller L, Pfeffer M, Neubauer H, Tomaso H. 2009. Identification and antimicrobial susceptibilities of Ochrobactrum spp. Int. J. Med. Microbiol. 299: 209-220.
26. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M. 2011. Enterotypes of the human gut microbiome. Nature 473: 174-180.
27. Marshall BM, Ochieng DJ, Levy SB. 2009. Commensals: underappreciated reservoir of antibiotic resistance. Microbe 4: 231-238.
28. Cuadrado V, Gomila M, Merini L, Giulietti AM, Moore ER. 2010. Cupriavidus pampae sp. nov., a novel herbicide-degrading bacterium isolated from agricultural soil. Int. J. Syst. Evol. Microbiol. 60: 2606-2612.
29. Scholz HC, Pfeffer M, Witte A, Neubauer H, Al Dahouk S, Wernery U, Tomaso H. 2008. Specific detection and differentiation of Ochrobactrum anthropi, Ochrobactrum intermedium and Brucella spp. by a multiprimer PCR that targets the recA gene. J. Med. Microbiol. 57: 64-71.
30. Scholz HC, Tomaso H, Al Dahouk S, Witte A, Schloter M, Kampfer P, Falsen E, Neubauer H. 2006. Genotyping of Ochrobactrum anthropi by recA-based comparative sequence, PCR-RFLP, and 16S rRNA gene analysis. Fems Microbiol. Lett. 257: 7-16.
31. Bolmstrom A, Arvidson S, Ericsson M, Karlsson A. 1988. A novel technique for direct quantification of antimicrobial susceptibility of microorganisms, abstr. 1209. Program Abstr. 28th Intersci. Conf. Animicrobial Agents Chemother.
32. Brown DF, Brown L. 1991. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J. Antimicrob. Chemother. 27: 185-190.
33. Marmur J. 1961. A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J. Mol. Biol. 3: 208-218.
34. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen Y-J, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer MLI, Jarvie TP, Jirage KB, Kim J-B, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF, Rothberg JM. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376-380.
35. Gillespie JJ, Wattam AR, Cammer SA, Gabbard J, Shukla MP, Dalay O, Driscoll T, Hix D, Mane SP, Mao C. 2011. PATRIC: the comprehensive bacterial bioinformatics resource with a focus on human pathogenic species. Infect. Immun. 79: 4286-4298.
36. Teyssier C, Marchandin H, Masnou A, Jeannot JL, Siméon de Buochberg M, Jumas-Bilak E. 2005. Pulsed-field gel electrophoresis to study the diversity of whole-genome organization in the genus Ochrobactrum. Electrophoresis 26: 2898-2907.
37. Kent WJ. 2002. BLAT-the BLAST-like alignment tool. Genome Res. 12: 656-664.
38. Liu B, Pop M. 2009. ARDB-Antibiotic Resistance Genes Database. Nucleic Acids Res. 37: D443-D447.
39. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
40. Jacoby GA. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22: 161-182.
41. Boulund F, Johnning A, Pereira MB, Larsson DGJ, Kristiansson E. 2012. A novel method to discover fluoroquinolone antibiotic resistance (qnr) genes in fragmented nucleotide sequences. BMC Genomics 13: 695.
42. Guglielmini J, de la Cruz F, Rocha EP. 2013. Evolution of conjugation and type IV secretion systems. Mol. Biol. Evol. 30: 315-331.
43. Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. 2006. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 34: D32-D36.
44. Toleman MA, Bennett PM, Walsh TR. 2006. ISCR elements: novel gene-capturing systems of the 21st century? Microbiol. Mol. Biol. Rev. 70: 296-316.
45. Scholz HC, Al Dahouk S, Tomaso H, Neubauer H, Witte A, Schloter M, Kämpfer P, Falsen E, Pfeffer M, Engel M. 2008. Genetic diversity and phylogenetic relationships of bacteria belonging to the Ochrobactrum-Brucella group by recA and 16S rRNA gene-based comparative sequence analysis. Syst. Appl. Microbiol. 31: 1-16.
46. Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, RodloffAC, Rossolini GM. 2013. EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. 19: 141-160.
47. Roberts MC. 1996. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol. Rev. 19: 1-24.
48. Frost LS, Ippen-Ihler K, Skurray RA. 1994. Analysis of the sequence and gene products of the transfer region of the F sex factor. Microbiol. Rev. 58: 162.
49. Levings RS, Djordjevic SP, Hall RM. 2008. SGI2, a relative of Salmonella genomic island SGI1 with an independent origin. Antimicrob. Agents Chemother. 52: 2529-2537.
50. Cloeckaert A, Baucheron S, Chaslus-Dancla E. 2001. Nonenzymatic chloramphenicol resistance mediated by IncC plasmid R55 is encoded by a floR gene variant. Antimicrob. Agents Chemother. 45: 2381.
51. Gaffney DF, Cundliffe E, Foster T. 1981. Chloramphenicol resistance that does not involve chloramphenicol acetyltransferase encoded by plasmids from gram-negative bacteria. J. Gen. Microbiol. 125: 113.
52. Mahillon J, Chandler M. 1998. Insertion sequences. Microbiol. Mol. Biol. Rev. 62: 725-774.
53. Hopkins KL, Davies RH, Threlfall EJ. 2005. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob. Agents 25: 358-373.
54. Jacoby GA. 2009. Plasmid-mediated quinolone resistance, p 207-210. In Mayers DL (ed), Antimicrobial drug resistance. Humana Press, New York, NY.
55. Aoki T, Satoh T, Kitao T. 1987. New tetracycline resistance determinant on R plasmids from Vibrio anguillarum. Antimicrob. Agents Chemother. 31: 1446-1449.
56. Triman KL. 1996. The 16S ribosomalRNAmutation database (16SMDB). Nucleic Acids Res. 24: 166-168.
57. Vester B, Douthwaite S. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45: 1-12.
58. Higgins CS, Avison MB, Jamieson L, Simm AM, Bennett PM, Walsh TR. 2001. Characterization, cloning and sequence analysis of the inducible Ochrobactrum anthropi AmpC β-lactamase. J. Antimicrob. Chemother. 47: 745-754.
59. Livermore DM, Hope R, Fagan EJ, Warner M, Woodford N, Potz N. 2006. Activity of temocillin against prevalent ESBL-and AmpC-producing Enterobacteriaceae from south-east England. J. Antimicrob. Chemother. 57: 1012-1014.
60. Smillie C, Garcillán-Barcia MP, Francia MV, Rocha EP, de la Cruz F. 2010. Mobility of plasmids. Microbiol. Mol. Biol. Rev. 74: 434-452.
61. Toleman MA, Walsh TR. 2011. Combinatorial events of insertion sequences and ICE in Gram-negative bacteria. FEMS Microbiol. Rev. 35: 912-935.
62. Arcangioli MA, Leroy-Sétrin S, Martel JL, Chaslus-Dancla E. 1999. A new chloramphenicol and florfenicol resistance gene flanked by two integron structures in Salmonella typhimurium DT104. FEMS Microbiol. Lett. 174: 327-332.
63. Rådström P, Swedberg G, Sköld O. 1991. Genetic analyses of sulfonamide resistance and its dissemination in gram-negative bacteria illustrate new aspects of R plasmid evolution. Antimicrob. Agents Chemother. 35: 1840-1848.
64. Wilson NL, Hall RM. 2010. Unusual class 1 integron configuration found in Salmonella genomic island 2 from Salmonella enterica serovar Emek. Antimicrob. Agents Chemother. 54: 513-516.